Category Archives: News, events, & announcements

Golden Helix Named as Top 10 World’s Most Trust Worthy Bioanalysis Companies in 2020

         March 13, 2020

Today, CIO Look announced their collection of the Top 10 World’s Most Trust Worthy Bioanalysis Companies in 2020. We are incredibly honored to have received this award and being recognized amongst the top biotech companies! You can access the publication here: https://ciolook.com/golden-helix-inc-empowering-healthcare-organizations-with-industry-leading-next-generation-sequencing-analysis-software/. As always, we would not be receiving this recognition without the incredible support from our community. Thank you… Read more »

2020 Abstract Competition Winners

         February 18, 2020
2020 Abstract Competition Winners

We would like to thank everyone who entered our 2020 Abstract Competition. It is wonderful to read about the different ways Golden Helix software is being applied around the world. It is our pleasure to announce this year’s winners! First Place: Dr. Robert Hamilton and Priyanka Kugamoorthy – SickKids Yearly Clinical Review of a Patient’s WGS Results Leads to a… Read more »

Golden Helix Recognized as one of the Top 60 Genetics Blogs on the Web

         February 11, 2020

We are incredibly grateful to be recognized as one of the Top 60 Genetics Blogs on the Web by Feedspot. Our team is dedicated to educating our readers on how our solutions can help enable precision medicine, and we are so honored to have received this recognition.  On our blog, you will discover posts touching on important topics, like cyber security strategies,… Read more »

Introducing Drugs & Trials for Cancer Diagnostics

         January 23, 2020

When interpreting a variant using the AMP/ASCO guidelines for somatic variant interpretation, clinicians must determine whether the variant can be considered a biomarker that affects clinical care by predicting sensitivity, resistance, or toxicity to a specific therapy. Such a determination requires the investigation of multiple evidence sources, including clinical trials, FDA approved therapies and peer-reviewed studies. Unfortunately, strong evidence linking… Read more »

Off to PAG XXVIII!

         January 7, 2020

We’re packing our bags and getting ready to head out to San Diego, CA for the International Plant & Animal Genome XXVIII meeting (or PAG 2020). This is the largest ag-genomics meeting in the world, bringing together over 3,000 leading genetic scientists and researchers in plant and animal research, and over 120 exhibits, 140+ workshops, 1000+ posters, and 1700+ abstracts. We… Read more »

Fast Annotations Around the Globe: Our Sydney and Frankfurt Data Mirrors

         December 3, 2019
Customer Publications

If you have watched this blog over time, it would be no surprise that Golden Helix invests a lot in curating genomic annotations for use with our clinical and research analysis products. Often, we spend considerable time on the attention to detail necessary to ensure the best experience for any data source by cleaning, normalizing, documenting and then distributing it through our data annotation server. Many annotations… Read more »

Reflecting on AMP 2019

         November 14, 2019

Our team has returned from the annual meeting of the Association of Molecular Pathology (AMP 2019), and, as always, I am grateful for all the wonderful experiences we are bringing back with us. The plenary sessions and talks were bountiful, and we were very impressed with the well-organized exhibition. Hats off to everyone involved in planning this great event! Innovation… Read more »

Reflecting on ASHG 2019

         October 22, 2019

As our team returns from another successful ASHG conference, I would like to reflect on the great memories, connections, and future plans that were made at this meeting. First, I will start by thanking everyone involved with the superb planning and execution of the conference. We are thankful to have this opportunity to connect with our customers, partners, and friends… Read more »

Headed to Houston, TX for ASHG 2019

         October 14, 2019
ASHG 2019

Our team is getting ready to head to Houston, Texas for the American Society of Human Genetics Annual Meeting (ASHG) 2019. We are looking forward to spending the week discussing genetics with new and familiar faces! If you are planning on attending, please stop by our booth and say hello! You will find the Golden Helix team in booth 601…. Read more »

Golden Helix Named to the 2019 Inc. 5000 List of Fastest-Growing Private Companies

         August 16, 2019
Inc 5000

Earlier this week, Inc. magazine ranked Golden Helix on the 2019 Inc. 5000 list with three-year revenue growth of 61%. The Inc. 5000 list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. Microsoft, Dell, Domino’s Pizza, Pandora, Timberland, LinkedIn, Yelp, Zillow, and many other well-known names gained their first… Read more »

2019 T-Shirt Design Competition Winners

         August 15, 2019
T-Shirt Design Competition

We would like to thank everyone who participated in our 2019 t-shirt design competition. It was great to see the amount of creativity our community expressed! We are pleased to announce this year’s winners: First Place – Dr. Marina Trigueros Dr. Marina Trigueros is a Science Illustrator and 3D Animator at Cariboo Design, a studio devoted to explaining scientific topics… Read more »

Limited-Time Offer for VSClinical’s Cancer Add-On

         June 27, 2019

We are upgrading all VSClinical +Cancer Add-On purchases to a 15-months license! The individualized nature of tumors requires genomic testing for providing the best outcomes for patients. Next-Gen Sequencing enables the detection of small mutations, copy number changes, and common fusions affordably and with high precision. However, the interpretation of these detected variants is arduous without a comprehensive analytical workflow… Read more »

New eBook Release: Clinical Variant Analysis for Cancer

         June 6, 2019

Applying AMP Guidelines to Analyze Somatic Variants Today, I am thrilled to share with you the launch of a brand new eBook titled “Clinical Variant Analysis for Cancer – Applying AMP Guidelines to Analyze Somatic Variants”. We would happy to send you a complimentary copy which can be requested on our website here. The clinical utilization of Next-Gen Sequencing data… Read more »

Genetic Testing for Cancer – New Version Release

         June 5, 2019

Yesterday, I released a new version of my eBook, “Genetic Testing for Cancer – Third Edition”. We would be happy to send you one! To download a complimentary copy, please submit a request on our site here. In 1914, the German cytologist Theodor Boveri coined the phrase “Cancer is a disease of the genome.” At this time, his ideas were… Read more »

Golden Helix Receives NIH-SBIR Phase 2 Grant 2R44 GM128485-02

         March 28, 2019

Golden Helix, Inc. has announced themselves as the recipient of an NIH SBIR Grant 2R44GM128485-02 entitled “Automated and Guided Workflows for Clinical Testing Using NGS Assays.” “With the help of this grant, we will take the clinical automation of NGS data to the next level, focusing on germline diseases and cancer diagnostics,” states Andreas Scherer, Ph.D., President, and CEO of… Read more »

2019 Abstract Competition Winners

         February 25, 2019
Call for Abstracts

We would like to thank everyone who entered our 2019 Abstract Competition. This event is an excellent opportunity for our team to hear the unique ways Golden Helix software is being applied around the world. We had a number of remarkable entries this year which made our selection process a daunting one, indeed. It is my pleasure to announce this… Read more »

New eBook Release: Clinical Variant Analysis

         February 18, 2019

I am excited to announce the release of my new eBook “Clinical Variant Analysis – Applying ACMG Guidelines to Analyze Germline Diseases“! You can download your complimentary by clicking on the button below. The clinical interpretation of variants in Next-Gen Sequencing is a quickly evolving field. While the body of knowledge is growing exponentially, experts have to derive sound, clinical decisions leveraging an… Read more »